Asia Pacific Radiopharmaceuticals Market
The Asia Pacific Radiopharmaceuticals Market size was valued at US$ 1,384.59 Mn in 2021 and is projected to reach US$ 2,661.38 Mn by 2028, growing at a CAGR of 9.8% during 2021 - 2028.
Report Coverage
- Type: Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine
- Application: Oncology, Cardiology, Neurology
- End User: Hospitals, Imaging Centers, Academic and Research Centers
US$ 1,384.59 Mn
Market size in 2021
US$ 2,661.38 Mn
Market Size by 2028
9.8%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Radiopharmaceuticals Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Radiopharmaceuticals Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Radiopharmaceuticals Market Regional Analysis
6.2 Asia Pacific Radiopharmaceuticals Market Revenue 2019-2028 (US$ Million)
6.3 Asia Pacific Radiopharmaceuticals Market Forecast Analysis
7. Asia Pacific Radiopharmaceuticals Market Analysis – by Type
7.1 Diagnostic Nuclear Medicine
- 7.1.1 Overview
- 7.1.2 Diagnostic Nuclear Medicine: Asia Pacific Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Therapeutic Nuclear Medicine
- 7.2.1 Overview
- 7.2.2 Therapeutic Nuclear Medicine: Asia Pacific Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Asia Pacific Radiopharmaceuticals Market Analysis – by Application
8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: Asia Pacific Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Cardiology
- 8.2.1 Overview
- 8.2.2 Cardiology: Asia Pacific Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Neurology
- 8.3.1 Overview
- 8.3.2 Neurology: Asia Pacific Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Asia Pacific Radiopharmaceuticals Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Asia Pacific Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Imaging Centers
- 9.2.1 Overview
- 9.2.2 Imaging Centers: Asia Pacific Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Academic and Research Centers
- 9.3.1 Overview
- 9.3.2 Academic and Research Centers: Asia Pacific Radiopharmaceuticals Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Asia Pacific Radiopharmaceuticals Market – Asia-Pacific Analysis
10.1 Overview
10.2 Asia-Pacific- 10.2.1 Asia Pacific Radiopharmaceuticals Market Breakdown, by Key Country, 2022 and 2028 (%)
- 10.2.1.1 Asia Pacific Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 China: Asia Pacific Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 China: Asia Pacific Radiopharmaceuticals Market Breakdown, by Type
- 10.2.1.1.2 China: Asia Pacific Radiopharmaceuticals Market Breakdown, by Application
- 10.2.1.1.3 China: Asia Pacific Radiopharmaceuticals Market Breakdown, by End User
- 10.2.1.2 India: Asia Pacific Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 India: Asia Pacific Radiopharmaceuticals Market Breakdown, by Type
- 10.2.1.2.2 India: Asia Pacific Radiopharmaceuticals Market Breakdown, by Application
- 10.2.1.2.3 India: Asia Pacific Radiopharmaceuticals Market Breakdown, by End User
- 10.2.1.3 Japan: Asia Pacific Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Japan: Asia Pacific Radiopharmaceuticals Market Breakdown, by Type
- 10.2.1.3.2 Japan: Asia Pacific Radiopharmaceuticals Market Breakdown, by Application
- 10.2.1.3.3 Japan: Asia Pacific Radiopharmaceuticals Market Breakdown, by End User
- 10.2.1.4 Australia: Asia Pacific Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Australia: Asia Pacific Radiopharmaceuticals Market Breakdown, by Type
- 10.2.1.4.2 Australia: Asia Pacific Radiopharmaceuticals Market Breakdown, by Application
- 10.2.1.4.3 Australia: Asia Pacific Radiopharmaceuticals Market Breakdown, by End User
- 10.2.1.5 Rest of Asia-Pacific : Asia Pacific Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Radiopharmaceuticals Market Breakdown, by Type
- 10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Radiopharmaceuticals Market Breakdown, by Application
- 10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Radiopharmaceuticals Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Advanced Accelerator Applications
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Bayer AG
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Bracco Imaging S.p.A
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Cardinal Health Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Curium
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 ECZACIBAI MONROL NUCLEAR PRODUCTS CO.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 GENERAL ELECTRIC
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Lantheus Medical Imaging, Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Nordion
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 NTP RADIOISOTOPES
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
